OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative Efficacy of Oral Calcitonin-Gene–Related Peptide Antagonists for the Treatment of Acute Migraine: Updated Meta-analysis
Dong Kyoung Ha, Min Ji Kim, Nayoung Han, et al.
Clinical Drug Investigation (2021) Vol. 41, Iss. 2, pp. 119-132
Closed Access | Times Cited: 25

Showing 25 citing articles:

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Richard B. Lipton, Robert Croop, David Stock, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 3, pp. 209-217
Closed Access | Times Cited: 88

Pharmacologic Treatment of Acute Attacks of Episodic Migraine: A Systematic Review and Network Meta-analysis for the American College of Physicians
Gerald Gartlehner, Andreea Dobrescu, Gernot Wagner, et al.
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 3

Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
Hannah A. Blair
CNS Drugs (2023) Vol. 37, Iss. 3, pp. 255-265
Open Access | Times Cited: 28

Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies
Irene de Boer, Iris E. Verhagen, Marcio Nattan Portes Souza, et al.
Cephalalgia (2023) Vol. 43, Iss. 2
Open Access | Times Cited: 23

Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
Karissa Johnston, Linda Harris, Lauren Powell, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 32

Macrocyclization strategy for improving candidate profiles in medicinal chemistry
Om Darlami, R.Y.K. Pun, Sung‐Hoon Ahn, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116501-116501
Closed Access | Times Cited: 6

Trends in utilization and costs of migraine medications, 2017–2020
Jennifer L. Nguyen, Kiraat D. Munshi, Samuel K. Peasah, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 23

Chronic orofacial pain and pharmacological management – a Clinical guide
Guangzhao Guan, A Polonowita, Li Mei, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2025)
Open Access

New Approaches to Shifting the Migraine Treatment Paradigm
Brian F. G. Johnson, Frederick G. Freitag
Frontiers in Pain Research (2022) Vol. 3
Open Access | Times Cited: 18

Efficacy and tolerability of the ketogenic diet and its variations for preventing migraine in adolescents and adults: a systematic review
Madson C Caminha, Adriana Boschi Moreira, Filipe C. Matheus, et al.
Nutrition Reviews (2021) Vol. 80, Iss. 6, pp. 1634-1647
Closed Access | Times Cited: 22

Safety and Efficacy of Calcitonin Gene-related Peptide Receptor Antagonists and Selective Serotonin Receptor Agonist in the Management of Migraine: A Systematic Review and Meta-analysis
Pooja Singh, Rakesh Kumar Ponnada, Ruchika Sharma, et al.
CNS & Neurological Disorders - Drug Targets (2024) Vol. 23, Iss. 12, pp. 1474-1487
Closed Access | Times Cited: 2

A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine
Nazir Noor, Alexis Angelette, Abby Lawson, et al.
Health psychology research (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 10

Safety evaluation of oral calcitonin-gene–related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis
Seo Yeon Lee, Christine E. Staatz, Nayoung Han, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 9, pp. 1365-1376
Closed Access | Times Cited: 8

The pharmacotherapeutic management of episodic and chronic migraine with gepants
János Tajti, Délia Szok, Anett Csáti, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 8, pp. 947-958
Open Access | Times Cited: 4

Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein–Ligand Complexes
Andrew D. Cansfield, Mark A. Ator, Joydeep Banerjee, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 6, pp. 751-765
Closed Access | Times Cited: 7

CGRP and CGRP-Receptor as Targets of Migraine Therapy: Brain Prize-2021
László Vécsei, János Tajti, Délia Szok, et al.
CNS & Neurological Disorders - Drug Targets (2021) Vol. 21, Iss. 6, pp. 460-478
Open Access | Times Cited: 9

Effectiveness of Calcitonin Gene-Related Peptide Receptor Antagonists for Migraine Treatment: A Meta-Analysis
Kyoungjune Pak, Jiyoung Kim, Gha-Hyun Lee, et al.
European Neurology (2022) Vol. 85, Iss. 3, pp. 195-201
Closed Access | Times Cited: 6

Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies
Vinícius Lins Ferreira, Felipe F. Mainka, Astrid Wiens, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 9, pp. 669-680
Closed Access | Times Cited: 2

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide in Migraine Pathogenesis
Alexey Y. Sokolov, Anastasiia V. Osipchuk, I. B. Skiba, et al.
Neurochemical Journal (2022) Vol. 16, Iss. 1, pp. 31-38
Closed Access | Times Cited: 3

Migraine pharmacology and brain ischemia
R. S. Mirzoyan, Gan'shina Ts, Il'ya N. Kurdyumov, et al.
Research Results in Pharmacology (2021) Vol. 7, Iss. 2, pp. 67-82
Open Access | Times Cited: 3

Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding Mode
Stacey M. Southall, Joydeep Banerjee, Jason Brown, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 11, pp. 1776-1782
Open Access | Times Cited: 1

Acute Treatments for Episodic Migraine: Surveillance Report 2
Juliana H. Vande Pluym, Rashmi B. Halker Singh, Magdoleen H. Farah, et al.
(2022)
Open Access

Page 1

Scroll to top